## **Core Concept**
Carotid body tumors, also known as carotid body paragangliomas, are rare, usually benign neoplasms that arise from the paraganglia located in the carotid bifurcation. These tumors are part of the paraganglioma system, which includes both chromaffin and non-chromaffin paraganglia. The carotid body is a non-chromaffin paraganglion.
## **Why the Correct Answer is Right**
The correct answer encompasses several key characteristics of carotid body tumors:
- **a) Non-chromaffin paraganglioma**: Carotid body tumors originate from the non-chromaffin paraganglia. Unlike pheochromocytomas, which are chromaffin paragangliomas, carotid body tumors do not typically secrete catecholamines.
- **b) Good prognosis**: The majority of carotid body tumors are benign and have a good prognosis, especially when they can be completely surgically resected.
- **c) Rarely metastasizes**: While the majority are benign, a small percentage of carotid body tumors can be malignant, but metastasis is rare.
- **d) Similar to mixed parotid tumor**: This option might seem confusing because carotid body tumors are not similar to mixed parotid tumors (pleomorphic adenomas) in terms of their origin, histology, or clinical behavior.
## **Why Each Wrong Option is Incorrect**
- **Option D:** Carotid body tumors are not similar to mixed parotid tumors. Mixed parotid tumors (pleomorphic adenomas) are the most common type of benign salivary gland tumor and have a different histological appearance and clinical behavior compared to carotid body tumors.
## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that while carotid body tumors are usually benign, familial cases (which account for about 10% of cases) are more likely to be bilateral, multicenter, or malignant. Screening for familial cases involves checking for mutations in the SDHB, SDHC, and SDHD genes.
## **Correct Answer: A.**
Free Medical MCQs Β· NEET PG Β· USMLE Β· AIIMS
Access thousands of free MCQs, ebooks and daily exams.
By signing in you agree to our Privacy Policy.